Sonja Krösser, PhD, Novaliq’s Head of Clinical Development, discusses research around the late-stage compounds NOV03 and CyclASol. The former being developed to treat evaporative DED associated with meibomian gland dysfunction. CyclASol, ophthalmic solution of 0.1% cyclosporine A in EyeSol, is an anti-inflammatory and immunomodulating drug […]

Industry Spotlight: Novaliq

Innovation in dry eye disease diagnostics and therapeutics has increased dramatically in the last few years. Join Scott Schachter, OD, and Christopher Starr, MD, as they meet with the researchers behind each committee of the global dry eye consensus, TFOS DEWS II. Optometrists and ophthalmologists who want to start or ramp up their dry eye practice should tune in and subscribe, as each episode will feature clinical takeaways.

Share Industry Spotlight: Novaliq

Sign up to save your podcasts

Industry Spotlight: Novaliq

Industry Spotlight: Novaliq